Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Interferon-Beta Therapy of Multiple Sclerosis Patients Improves the Responsiveness of T Cells for Immune Suppression by Regulatory T Cells.
Electroactive biodegradable polyurethane significantly enhanced Schwann cells myelin gene expression and neurotrophin secretion for peripheral nerve tissue engineering.
A New Method to Segment the Multiple Sclerosis Lesions on Brain Magnetic Resonance Images.
PET Imaging Study of S1PR1 Expression in a Rat Model of Multiple Sclerosis.
The role of Candida albicans in the severity of multiple sclerosis.
Effect of 10-day forced treadmill training on neurotrophic factors in experimental autoimmune encephalomyelitis.
Balance deficit with opened or closed eyes reveals involvement of different structures of the central nervous system in multiple sclerosis.
Paraneoplastic isaacs' syndrome: a case series and review of the literature.
Mesenchymal cells of umbilical cord and umbilical cord blood as a source of human oligodendrocyte progenitors.
Small molecules with anti-inflammatory properties in clinical development.
Involvement of membrane skeletal molecules in the Schmidt-Lanterman incisure in Schwann cells.
Mosaicism for GJB1 mutation causes milder Charcot-Marie-Tooth X1 phenotype in a heterozygous man than in a manifesting heterozygous woman.
Matrix metalloproteinases and their pathological upregulation in multiple sclerosis: an overview.
Longitudinal T cell-derived IFN-γ/IL-17 balances do not correlate with the disease course in two mouse models of experimental autoimmune encephalomyelitis.
Chronic inflammatory demyelinating polyneuropathy with papillodema and response to immunoglobulins.
Autophagy-related gene16L2, a potential serum biomarker of multiple sclerosis evaluated by bead-based proteomic technology.
Anti-N-Methyl-d-Aspartate Receptor Encephalitis Presenting With Features of Kleine-Levin Syndrome and Demyelination.
The melanocortin ACTH 1-39 promotes protection of oligodendrocytes by astroglia.
Correction: Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.
A Novel CMKLR1 Small Molecule Antagonist Suppresses CNS Autoimmune Inflammatory Disease.
Fatigue in Multiple Sclerosis Compared to Stroke.
Intracellular Protein Shuttling: A Mechanism Relevant for Myelin Repair in Multiple Sclerosis?
Biological role of Toll-like receptor-4 in the brain.
An electrophysiological classification associated with Guillain-Barré syndrome outcomes.
Blocking adhesion molecules as therapy for multiple sclerosis: natalizumab.

Pages